Uk's cma assessing anticipated pharm-a-care laboratories/p&g's haliborange deal

Uk's cma -considering whether anticipated pharm-a-care laboratories/p&g's haliborange deal will result in substantial lessening of competition in uk.

PG Ratings Summary

PG Quant Ranking